Background
Methods
French translation of VES-13
Validation of EVA-13
Statistical analysis
Results
Translation of VES-13
Feasibility and validation study
Variables | Participants (N = 135) | |
---|---|---|
Age (years, mean +/− SD and range) | 81.2 +/− 6.8 | 70–100 |
Female gender (n and %) | 90 | 66.7% |
Need human help for ADL (n and %) | 31 | 23.1% |
Subjects recruited from: | ||
prevention center (n and %) | 45 | 33.3% |
geriatric outpatient clinic (n and %) | 40 | 29.6% |
geriatric rehabilitation hospital unit (n and %) | 50 | 37.1% |
MMSE score (0–30, mean +/− SD and range) | 26.7 +/− 2.8 | 20–30 |
EVA-13 total score (mean +/SD and range) | 4.13 +/− 3.66 | 0–10 |
EVA-13 total score (median and interquartile range) | 3 | 1–8 |
Non-vulnerable, i.e. EVA-13 score < 3 (n and %) | 62 | 46.0% |
Vulnerable, i.e. EVA-13 score > 3 (n and %) | 73 | 54.0% |
Feasibility
Validity
Variable | Group 1 (n = 45) | Group 2 (n = 40) | Group 3 (n = 50) | p |
---|---|---|---|---|
Age (years, mean +/− SD) | 76.5 +/− 4.8 | 81.2 +/− 5.5 | 85.6 +/− 6.6 | < 10–4 |
Female gender (n and %) | 29 (64%) | 27 (67%) | 34 (68%) | 0.93 |
Need human help for ADL (n and %) | 1 (2%) | 10 (25%) | 20 (40%) | < 10–3 |
MMSE score (0–30, mean +/− SD) | 28.6 +/− 1.7 | 24.7 +/− 2.7 | 26.6 +/− 2.4 | 0.009 |
EVA-13 total score (mean +/SD) | 0.91 +/− 1.16 | 4.27 +/− 3.17 | 6.90 +/− 3.17 | < 10–4* |
Non-vulnerable, i.e. EVA-13 score < 3 (n and %) | 40 (89%) | 17 (42%) | 5 (10%) | < 10–3 |
Vulnerable, i.e. EVA-13 score > 3 (n and %) | 5 (11%) | 23 (58%) | 45 (90%) | < 10–3 |
Outcome at follow-up | p | ||
---|---|---|---|
Institutionnalized or dead (n = 26) | Alive and living at home (n = 104) | ||
Age (years) | 87.2 +/− 5.5 | 79.8 +/− 6.3 | < 10–4 |
Female gender (n, %) | 19 (73%) | 67 (64%) | 0.49 |
Need human help for ADL (n, %) | 11 (42%) | 19 (18%) | 0.01 |
Subjects recruited from: (n, %) | < 10–4 | ||
prevention center (Group 1) | 0 | 44 (43%) | |
geriatric outpatient clinic (Group 2) | 7 (27%) | 33 (31%) | |
rehabilitation hospital unit (Group 3) | 19 (73%) | 27 (26%) | |
MMSE (0–30) | 25.9 +/− 2.9 | 26.9 +/− 2.7 | 0.12 |
EVA-13 (0–10) | 7.61 +/− 2.81 | 3.23 +/− 3.30 | < 10–4* |
Vulnerable, i.e. EVA-13 Score > 3 | 24 (92%) | 46 (44%) | < 10–4 |